Dr. Darshan Bhatt
MD, M.Phil. (Retd. Wg. Cdr. IAF)
A Visionary Leader in Clinical Research and Pharmacovigilance
Dr. Darshan Bhatt, with over 45 years of experience in clinical medicine, biomedical research, and the pharmaceutical industry, is a trailblazer in drug safety and pharmacovigilance. His expertise spans leadership roles in esteemed organizations such as the Indian Air Force, AstraZeneca, Sciformix Technologies, and Strides Arcolab.
Renowned for his pioneering contributions to global drug development and safety systems, Dr. Bhatt has been instrumental in advancing clinical research standards and improving patient outcomes worldwide.
1. Career Overview
- Indian Air Force (1974–1996)
- Specialist Physician and Researcher, focusing on applied biomedical research.
- AstraZeneca (1996–2006)
- Global Drug Safety Physician, spearheading clinical development programs and regulatory engagements.
- Sciformix Technologies & MMS Holdings (2007–2015)
- Established offshore pharmacovigilance operations and mentored teams in risk management and safety surveillance.
- Strides Arcolab (2011–2012)
- Set up an in-house pharmacovigilance organization, guiding operations and compliance.
- Consultancy (2015–Present)
- Advisor and mentor in clinical research, pharmacovigilance, and aggregate safety reporting.
2. Key Skills and Expertise
- Clinical trial design and risk-based monitoring.
- Pharmacovigilance operations and regulatory compliance.
- Advanced data analysis and visualization (QlikView, QlikSense).
- Training and mentoring in drug safety and clinical research.
- Strategic planning for drug development and patient safety.
3. Publications
- Multiple peer-reviewed articles on drug development and safety systems.
- Contributor to pharmacovigilance workshops and industry conferences.
4. Awards and Honors
- Indian Air Force: Commendation for contributions to biomedical research.
- AstraZeneca UK: Recognized for global regulatory success and pivotal clinical trial contributions.
- Industry Recognition: Esteemed speaker and mentor in drug safety and pharmacovigilance initiatives globally.